Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study

<div>Study analysis populations. HAP: hospital-acquired pneumonia, VAP: ventilator-associated pneumonia, IIAT: inappropriate initial empiric antibiotic treatment, CRGNB: carbapenem-resistant Gram-negative bacteria, and TGC: tigecycline.</div>

BioMed Research International

fig1

Figure 1

Figure 1: Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study 

Figure 1 | Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study 